News
The latest GID BIO and cellular therapy news.
Two new employees join GID BIO team
GID BIO welcomes two new employees to the team as the newest of eight trial sites begin gearing up to enroll patients to participate in...
- GID BIO News
- December 10, 2021
- News
AdventHealth Orlando joins as newest trial site in pivotal trial
Tariq Awan, DO, a double-certified family and sports medicine physician with a special focus in sports medicine enters as GID BIO’s newest principal investigator in a pivotal Phase III trial evaluating cellular therapy for the treatment...
- GID BIO News
- October 7, 2021
- News
Professional athletes-turned physicians discuss the importance of cell therapy on The Ortho Show
Listen to former NFL players Jaime Garza, MD, DDS, FACS, one of GID BIO’s principal investigators, and Jim Kovach, MD, JD, as they reunite on...
- GID BIO News
- October 7, 2021
- Media
New trial site, the University of Pittsburgh Medical Center, joins GID BIO’s pivotal trial
New trial site, the University of Pittsburgh Medical Center, joins GID BIO's pivotal Phase III trial...
- GID BIO News
- October 7, 2021
- News
UC Davis joins as trial site in pivotal trial
Charles De Mesa, DO, MPH, a Northern California practicing specialist in anesthesiology and pain medicine, physical medicine and rehabilitation and musculoskeletal pain medicine is GID Bio's newest principal investigator in a pivotal trial...
- GID BIO News
- August 12, 2021
- News